Marshall Wace North America’s CRH Medical Corporation CRHM Stock Holding History

Marshall Wace North America’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,100	Closed	-$25K	–	2050
2018 Q4	$25K	Buy	+8,100	New	+$26.7K	﹤0.01%	1383
2018 Q3	–	Sell	-121,833	Closed	-$380K	–	1545
2018 Q2	$380K	Buy	+121,833	New	+$389K	﹤0.01%	1133
2018 Q1	–	Sell	-101,426	Closed	-$268K	–	1808
2017 Q4	$268K	Buy	+101,426	New	+$226K	﹤0.01%	1246

Other funds holding CRHM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

SCM

Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Marshall Wace North America's CRHM Position: Q1 2019 in Review

Marshall Wace North America sold out of CRH Medical Corporation (CRHM) in Q1 2019, closing a stake of 8,100 shares — an estimated $25K sold.

Marshall Wace North America first reported a position in CRHM in Q4 2017 and held it in 3 quarters. The position peaked at $380K in Q2 2018. 39 funds tracked by Wall St. Rank hold CRHM as of Q1 2019.

Marshall Wace North America reported no remaining CRH Medical Corporation position as of Q1 2019 after selling out during the quarter.
Marshall Wace North America sold 8,100 CRH Medical Corporation shares in Q1 2019, an estimated $25K.
Marshall Wace North America first reported a position in CRH Medical Corporation in Q4 2017 and held it in 3 quarters.
Marshall Wace North America's CRH Medical Corporation position peaked at $380K in Q2 2018.
39 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q1 2019.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.